Original Paper

Power of Genetic Association Studies in the Presence of Linkage Disequilibrium and Allelic Heterogeneity
Sheila A. Fisher^a, Cathryn M. Lewis<sup>a, b

a</sup>Division of Genetics and Molecular Medicine and
^bSGDP Centre, Institute of Psychiatry, King's College London, London, UK

Address of Corresponding Author

Hum Hered 2008;66:210-222 (DOI: 10.1159/000143404)

  Key Words

• Allelic association
• Case-control study
• Heterogeneity
• Linkage disequilibrium
• Mutations
• Sample size
• Transmission disequilibrium test
• Allelic heterogeneity

  Abstract

Objectives: The calculation of the power and sample size required for association studies is essential, particularly for follow-up of genome-wide association studies, where much genotyping is required to replicate the original finding and identify the true disease susceptibility mutation. Methods: In this paper, we derive equations for estimation of sample sizes for the transmission disequilibrium test (TDT) and for case-control studies, in the presence of allelic heterogeneity and indirect association - where the genotyped tagging SNP is in linkage disequilibrium (LD) with the true mutation. Using data from NOD2 and PTPN22, we show that the true sample sizes required to detect association may be incorrect when calculated under the assumption of a single mutation and complete LD with the genotyped marker. Results: The true sample sizes may be lower when allelic heterogeneity acts in a recessive model across mutations, or increased when mutations lie on different alleles of a common tagging SNP. Conclusion: Calculating power and sample size under a range of realistic models of LD and allelic heterogeneity is essential to ensure that association studies have sufficient power to detect mutations.

Copyright © 2008 S. Karger AG, Basel

  References

1.

Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 1996;273:1516-1517.

2.

Camp NJ: Genomewide transmission/disequilibrium testing - consideration of the genotypic relative risks at disease loci. Am J Hum Genet 1997;61:1424-1430.

3.

Camp NJ: Genomewide transmission/disequilibrium testing: A correction. Am J Hum Genet 1999;64:1485-1487.

4.

Knapp M: A note on power approximations for the transmission/disequilibrium test. Am J Hum Genet 1999;64:1177-1185.

5.

Abel L, Muller-Myhsok B: Maximum-likelihood expression of the transmission/disequilibrium test and power considerations. Am J Hum Genet 1998;63:664-667.

6.

Tu IP, Whittemore AS: Power of association and linkage tests when the disease alleles are unobserved. Am J Hum Genet 1999;64:641-649.

7.

Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.

8.

Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-606.

9.

Hampe J, Cuthbert A, Croucher PJP, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJS, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG: Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-1928.

10.

Carlton VEH, Hu XL, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC, Chang M, Catanese JJ, Leong DU, Ardlie KG, Kastner DL, Seldin MF, Criswell LA, Gregersen PK, Beasley E, Thomson G, Amos CI, Begovich AB: PTPN22 genetic variation: Evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005;77:567-581.

11.

Palo OM, Antila M, Silander K, Hennah W, Kilpinen H, Soronen P, Tuulio-Henriksson A, Kieseppa T, Partonen T, Lonnqvist J, Peltonen L, Paunio T: Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments. Hum Mol Genetics 2007, doi:10.1093/hmg/ddm207.

12.

Iles MM: Effect of mode of inheritance when calculating the power of a transmission disequilibrium test study. Hum Hered 2002;53:153-157.

13.

Xiong M, Guo S-W: The power of linkage detection by the transmission disequilibrium tests. Hum Hered 1998;48:295-312.

14.

Kirkwood BR. Essentials of Medical Statistics. Blackwell Scientific, 1988.

15.

Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJP, Mascheretti S, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG: The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-874.

16.

Barrett JC, Fry B, Maller J, Daly MJ: Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.

17.

Schaid DJ: Likelihoods and TDT for the case-parents design. Genet Epidemiol 1999;16:250-260.

18.

Begovich AB, Carlton VEH, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang QQ, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SYP, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ, Gregersen PK: A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004;75:330-337.

19.

Steer S, Lad B, Grumley JA, Kingsley GH, Fisher SA: Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: Evidence for an early onset/disease severity effect. Arthritis Rheum 2005;52:358-360.

20.

Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Moser KL, Begovich AB, Carlton VEH, Li W, Lee AT, Ortmann W, Behrens TW, Gregersen PK: Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005;76:561-571.

21.

Onengut-Gumuscu S, Buckner JH, Concannon P: A haplotype-based analysis of the PTPN22 locus in type 1 diabetes. Diabetes 2006;55:2883-2889.

22.

Slager SL, Huang J, Vieland VJ: Effect of allelic heterogeneity on the power of the transmission disequilibrium test. Genet Epidemiol 2000;18:143-156.

23.

McGinnis R: General equations for P-t, P-s, and the power of the TDT and the affected-sib-pair test. Am J Hum Genet 2000;67:1340-1347.

24.

Iles MM: On calculating the power of a TDT study - comparison of methods. Ann Hum Genet 2002;66:323-328.

25.

Chen WM, Deng HW: A general and accurate approach for computing the statistical power of the transmission disequilibrium test for complex disease genes. Genet Epidemiol 2001;21:53-67.

26.

Longmate JA: Complexity and power in case-control association studies. Am J Hum Genet 2001;68:1229-1237.

27.

de Bakker PIW, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D: Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-1223.

28.

Schaid DJ: Power and sample size for testing associations of haplotypes with complex traits. Ann Hum Genet 2006;70:116-130.

29.

Morris RW, Kaplan NL: On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002;23:221-233.

30.

Sham PC, Curtis D: An extended transmission/disequilibrium test (TDT) for multi- allele marker loci. Ann Hum Genet 1995;59:323-336.

31.

Clayton DG, Walker NM, Smyth DJ, Pask R, Cooper JD, Maier LM, Smink LJ, Lam AC, Ovington NR, Stevens HE, Nutland S, Howson JMM, Faham M, Moorhead M, Jones HB, Falkowski M, Hardenbol P, Willis TD, Todd JA: Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet 2005;37:1243-1246.

  Author Contacts

Dr. Cathryn M. Lewis
King's College London, Department of Medical and Molecular Genetics
8th Floor, Guy's Tower, Guy's Hospital
London SE1 9RT (UK)
Tel. +44 20 7188 2601, Fax +44 20 7188 2585, E-Mail cathryn.lewis@kcl.ac.uk

  Article Information

Received: July 13, 2007
Accepted after revision: October 30, 2007
Published online: July 9, 2008
Number of Print Pages : 13
Number of Figures : 2, Number of Tables : 6, Number of References : 31

  Publication Details

Human Heredity (International Journal of Human and Medical Genetics)

Vol. 66, No. 4, Year 2008 (Cover Date: October 2008)

Journal Editor: Devoto M. (Philadelphia, Pa.)
ISSN: 0001-5652 (Print), eISSN: 1423-0062 (Online)

For additional information: http://www.karger.com/HHE

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.